Contact Us

Malaika Vx Inc. is a Canadian life sciences company that is developing a novel vaccine technology focused on HIV-1 and emerging viral diseases. Our core antigen platform technology is the foundation of Malaika’s unique vaccine approach, combatting naturally occurring public health challenges and deliberate viral threats with precision and innovation